跳至主要内容
临床试验/CTRI/2024/06/068565
CTRI/2024/06/068565已完成4 期

Efficacy of Autologous Platelet Rich Fibrin (PRF) on successful closure rate in Type 1 Tympanoplasty : Open label randomized controlled trial

未提供1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年6月20日最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
50
试验地点
1
主要终点
To study the successful closure rate (complete graft uptake and healing of perforation) in experimental group (Type 1 tympanoplasty with Platelet rich fibrin) and control group (Type 1 tympanoplasty without Platelet rich fibrin).

研究概览

简要总结

Thesis Protocol Summary

 Title - “ Efficacy of Autologous Platelet Rich Fibrin (PRF) on successful closure rate in Type 1 Tympanoplasty : Open label randomized controlled trial ”

-        Dr Mehul Barfa

Objectives –

Primary:

1.     To study the successful closure rate (complete graft uptake and healing of perforation) in experimental group (Type 1 tympanoplasty with PRF) and control group (Type 1 tympanoplasty without PRF).

 2.Secondary:

  1. To assess the healing time for repair of perforation in experimental group (Type 1 tympanoplasty with PRF) and control group (Type 1 tympanoplasty without PRF).
  1. To assess hearing outcome in terms of A-B gap closure in the experimental and control groups after six months of surgery

 Justification- Use of PRF on the temporalis fascia as a graft material can have better dimensional stability, especially in large perforations. As it is a thin membrane, it does not impede sound conducting mechanism and subsequently leads to better outcome, particularly with respect to achieving an intact TM and hearing improvement .

 Study design - A randomized control trial , active control, open label study.

Randomization -  Systematic randomization using computer-based software.   STUDY DURATION: 18 MONTHS

 Sample size –  Total study population – 50

Case – 25 ,   control – 25

Methodology –  COM cases – inactive

In cases - Temporalis fascia placed beneath TM flap , platelet rich Fibrin (PRF) membrane will be placed over the tympanomeatal flap layer then gelfoam will be placed in EAC ,

In control - Temporalis fascia placed beneath TM flap , gel foam will be placed in EAC.

Patients will be followed up at 7 days , 1, 3 and 6 months and observe for Graft uptake – Full closure/ Residual perforation otoendoscopically , and note the time of healing.

And PTA will be performed at 3 and 6 months of surgery.

Autologus PRF preparations will be done from patients blood

30 ml of whole blood ,after process of centrifugation middle layer of PRF will be extracted and will be used for study .

 All the data will be collected in excel sheet and

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Age from 18 to 65 , inactive chronic otitis media mucosal type, hearing less than 50 db, unilateral case of chronic suppurative otitis media , Dry from last 4 weeks.

排除标准

  • Chronic otitis media squamous , Hearing loss more than 50 db , patient with active discharge , revision tympanoplasty , any co-morbidities like DM .

结局指标

主要结局

To study the successful closure rate (complete graft uptake and healing of perforation) in experimental group (Type 1 tympanoplasty with Platelet rich fibrin) and control group (Type 1 tympanoplasty without Platelet rich fibrin).

时间窗: Follow up the patients at 1,3and 6 months post intervention and observe for Graft uptake – Full closure/ Residual perforation.

次要结局

  • To assess healing time in repair of perforation

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Dr Mehul Barfa

AIIMS , Raipur

研究点 (1)

Loading locations...

相似试验